Erasmus Medical Center
CareDx, NanoString Collaborate to Develop Organ Transplant Rejection Test
CareDx will use NanoString's new Human Organ Transplant panel to develop HistoMap, a gene expression profiling test to identify allograft rejection.
ASHG: Dutch Nationwide NIPT Implementation Study Sees 42 Percent Uptake After First Year
During the first year of the TRIDENT-2 study, 74,000 women opted for NIPT, which was switched from in-house-developed platforms to Illumina's VeriSeq in May of this year.
Dutch Study Makes NIPT Available to All Women; Belgian Provider Cries Foul Over State Subsidy
Premium
Since April 1, noninvasive prenatal testing, provided by three university genetic centers, is available to all pregnant women in the Netherlands for €175 as part of the TRIDENT-2 study.
SkylineDx Follows Multiple Myeloma MDx With Collaborative Effort to Develop Therapy Selection Assay
Premium
The consortium aims to profile up to 800 multiple myeloma patient samples using the Affymetrix platform with a goal of developing a list of predictive biomarkers.